Combat Methamphetamine Epidemic Act of 2005
E67391
The Combat Methamphetamine Epidemic Act of 2005 is a U.S. federal law that restricts retail sales of pseudoephedrine and related precursors to curb the domestic production of methamphetamine.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Combat Methamphetamine Epidemic Act of 2005 canonical | 3 |
Statements (46)
| Predicate | Object |
|---|---|
| instanceOf |
United States federal law
ⓘ
drug control legislation ⓘ |
| addresses |
diversion of precursor chemicals
ⓘ
domestic methamphetamine production ⓘ |
| aimsTo |
prevent diversion of legal cold medicines to illicit drug manufacturing
ⓘ
protect public health and safety ⓘ reduce methamphetamine-related crime ⓘ |
| appliesTo |
retail sales of ephedrine
ⓘ
retail sales of phenylpropanolamine ⓘ retail sales of pseudoephedrine ⓘ |
| chemicalTarget |
ephedrine
ⓘ
phenylpropanolamine ⓘ pseudoephedrine ⓘ |
| country |
United States of America
ⓘ
surface form:
United States
|
| enforcedBy |
Drug Enforcement Administration
ⓘ
state and local law enforcement agencies ⓘ |
| hasEffect |
increased regulatory burden on retailers of pseudoephedrine products
ⓘ
reduced availability of precursor chemicals for methamphetamine production ⓘ |
| imposes |
30-day sales limits on pseudoephedrine purchases
ⓘ
daily sales limits on pseudoephedrine purchases ⓘ quantity limits on mail-order sales of pseudoephedrine ⓘ quantity limits on mobile vendor sales of pseudoephedrine ⓘ |
| legalArea |
controlled substances regulation
ⓘ
pharmaceutical regulation ⓘ |
| partOf | USA PATRIOT Improvement and Reauthorization Act of 2005 ⓘ |
| purpose |
to curb domestic production of methamphetamine
ⓘ
to restrict access to methamphetamine precursors ⓘ |
| regulates |
over-the-counter cold medicines containing ephedrine
ⓘ
over-the-counter cold medicines containing phenylpropanolamine ⓘ over-the-counter cold medicines containing pseudoephedrine ⓘ |
| relatedTo |
Controlled Substances Act
ⓘ
United States methamphetamine control policies ⓘ |
| requires |
customer identification for purchase of pseudoephedrine products
ⓘ
customer signature in a logbook for pseudoephedrine purchases ⓘ placement of pseudoephedrine products behind the counter ⓘ recordkeeping of pseudoephedrine sales by retailers ⓘ |
| sectorAffected |
over-the-counter drug manufacturers
ⓘ
pharmacies ⓘ retail stores ⓘ |
| shortName | CMEA ⓘ |
| subjectOf |
War on Drugs
ⓘ
surface form:
United States drug policy debates
public health discussions on methamphetamine abuse ⓘ |
| targets | methamphetamine production in clandestine laboratories ⓘ |
| typeOfRestriction |
point-of-sale controls
ⓘ
purchase quantity limits ⓘ recordkeeping requirements ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Combat Methamphetamine Epidemic Act of 2005 Description of subject: The Combat Methamphetamine Epidemic Act of 2005 is a U.S. federal law that restricts retail sales of pseudoephedrine and related precursors to curb the domestic production of methamphetamine.
Referenced by (3)
Full triples — surface form annotated when it differs from this entity's canonical label.